1. Department of Cardiology, Copenhagen University Hospital - Herlev and Gentofte, and Center for Translational Cardiology and Pragmatic Randomized Trials, Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark (N.D.J., D.M., T.B.)
2. Cardiovascular Division, Brigham and Women’s Hospital, Harvard Medical School, and Center for Cardiometabolic Implementation Science, Brigham and Women’s Hospital, Boston, Massachusetts (M.V., S.G.L.)
3. Cardiovascular Division, Brigham and Women’s Hospital, Harvard Medical School, and Center for Cardiometabolic Implementation Science, Brigham and Women’s Hospital, Boston, Massachusetts, and Kaiser Permanente San Francisco Medical Center and Division of Research, San Francisco, California (A.S.B.)
4. Cardiovascular Division, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts (B.L.C., S.D.S.)
5. Sanofi, Lyon, France (E.L.D., S.S.)
6. Sanofi, Swiftwater, Pennsylvania (M.M.L.)
7. Sanofi, Singapore (R.C.H.)
8. Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, and Department of Cardiology, Copenhagen University Hospital – Rigshospitalet, Copenhagen, Denmark (L.K.)
9. Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, and Respiratory Medicine Section, Department of Medicine, Copenhagen University Hospital – Herlev and Gentofte, Copenhagen, Denmark (P.S., J.U.S.J.)
10. Epidemiological Infectious Disease Preparedness, Statens Serum Institut, Copenhagen, Denmark (C.J.-M.M., T.G.K.).